Cinchona officinalis
What's the taxonomical classification of Cinchona officinalis?
Cinchona officinalis belongs to the kingdom Plantae and is categorized under the phylum Streptophyta. Within this group, it is classified under the class Equisetopsida and the subclass Magnoliidae. Following the taxonomic hierarchy further, it falls under the order Gentianaales and the family Rubiaceae. Finally, the plant is identified by its genus, Cinchona, and its specific species, officinalis.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Rubiaceae |
| Genus | Cinchona |
| Species | officinalis |
What are the morphological characteristics of this plant?
Cinconan officiinalis has an erect, woody stem that grows into a medium-sized tree reaching heights of up to 10 meters with simple, opposite leaves that are elliptical or oblong in shape. The leaf margins are typically entire, and the surface often displays a glossy texture with prominent pinnate venation. Small, tubular white or pinkish flowers emerge in terminal cymes, which eventually develop into small, fleshy drupes containing seeds. The bark is thick and brownish, serving as the primary source for quinine extraction. These structural characteristics allow the plant to thrive in tropical rainforest environments.
What is the geographical distribution of this plant?
This plant is native to the humid tropical montane forests of the Andes Mountains in South America, specifically spanning across countries such as Peru, Ecuador, and Colombia. It thrives primarily at high elevations where the climate remains consistently moist and temperate. Within these mountainous ecosystems, the species occupies specific ecological niches characterized by rich soil and significant rainfall. While its natural range is strictly limited to these South American highlands, its historical importance led to various attempts at introduction in other tropical regions. Understanding this specific distribution is essential for studying the plant's natural habitat requirements.
How is this plant cultivated?
This plant Cinchona officinalis is cultivated in tropical and subtropical highland regions with well-drained, acidic soils and high humidity to optimize bark production.
Growers typically plant seeds in shaded nurseries before transplanting the saplings into permanent plantations once they are established. Regular maintenance requires careful monitoring of rainfall patterns and the prevention of soil erosion on hilly terrains. The trees are often grown in polycultures to maintain biodiversity and soil health.
After several years of growth, the bark is harvested by stripping it from the trunk and branches to extract quinine.
What parts of this plant are used medicinally?
This plant Cinchona officinalis is primarily utilized for its medicinal bark, which contains potent alkaloids like quinine. When the bark is harvested and dried, it serves as a crucial source for treating malaria and other febrile illnesses. The extraction of these specific compounds has historically been vital for managing parasitic infections in the bloodstream. Beyond its traditional uses, researchers continue to study the chemical properties found within the bark for various pharmaceutical applications. This bark remains the most significant part of the plant for therapeutic purposes.
According to a study published by "Open veterinary journal", the barks of Cinchona officinalis are used medicinally. The toxicity of its ethanolic extracts was evaluated using the larval form of GM. The hydroalcoholic extract of the Cinchona officinalis bark exhibited a high toxicity. Specifically, its LD50 was measured at 4.81 g/kg bw.
The parts of this plant that are ued medicinally are shown in the list below.
- bark
What traditional systems uses this plant?
This plant, known as cinchona, has been utilized for centuries in various traditional healing practices to treat malaria and other febrile illnesses. Indigenous communities in the Andean regions were the first to recognize the medicinal potency of its bitter bark. In Colombian folk medicine, preparations made from the bark were frequently employed to manage fever and digestive ailments. Historical use by European explorers eventually led to the isolation of quinine, which revolutionized global malaria treatment. These traditional applications laid the essential groundwork for modern pharmaceutical developments involving alkaloid extraction.
According to a study published by "BMC complementary and alternative medicine", Cinchona officinali s L. is one of the medicinal plants used in Colombian folk medicine to treat infections of microbial origin. These plants were collected by farmers and traditional healers. The study evaluated the antimicrobial activity of the plant against five bacteria, including Staphylococcus aureus, Streptococcus beta hemolytic, Bacillus cereus, Pseudomonas aeruginosa, and Escherichia coli, as well as one yeast, Candida albicans. While the research tested various extracts, the specific efficacy and Minimal Inhibitory Concentration values for Cinchona officinali s L. were not detailed beyond its inclusion in the screening. All the plants selected for this study were effective against three or more of the pathogenic microorganisms.
The hystorical systems that uses this plant are shown in the list below.
- Colombian folk medicine
What are the pharmacological activities of Cinchona officinalis?
This plant has potent anti-malarial, antiparasitic, antiplasmodial, antimicrobial, and antibacterial pharmacological activities. Its most famous alkaloid, quinine, serves as a primary treatment for malaria by targeting the parasite within the bloodstream. The chemical constituents also demonstrate significant antiplasmodial properties that combat blood-borne protozoa. Furthermore, the various alkaloids extracted from the bark exhibit broad antimicrobial effects against various pathogens. These diverse biological actions make the species a vital source for treating both parasitic infections and bacterial ailments.
According to a study published by "Current topics in medicinal chemistry", the cinchona alkaloid cinchonine is commercially extracted from the Peruvian bark of Cinchona officinalis L. This compound has been historically used as an anti-malarial agent and possesses various biological properties, including anti-cancer, anti-obesity, anti-inflammatory, anti-parasitic, antimicrobial, anti-platelet aggregation, and anti-osteoclast differentiation activities. It induces anti-cancer activity by activating caspase-3 and PARP-1, which triggers the endoplasmic reticulum stress response through the up-regulation of GRP78 and the phosphorylation of PERK and ETIF-2α. Furthermore, cinchonine inhibits osteoclastogenesis by inhibiting TAK1 activation and suppressing NFATc1 expression through the regulation of AP-1 and NF-κB. These pharmacological effects make it a promising compound for various therapeutic applications.
The primary pharmacological activities of this plant are shown in the list below.
- anti-malarial
- antimalarial
- antiparasitic
- antiplasmodial
- antibacterial
What medicinal compounds this plant contains?
This plant contains several key alkaloids, most notably quinine, quinidine, cinchonine, and cinchonidine. Quinine is the most significant compound because it serves as a powerful antimalarial agent used to treat infections caused by Plasmodium parasites. Quinidine is another essential derivative frequently utilized in medicine to manage cardiac arrhythmias by regulating heart rhythms. The other alkaloids, cinchonine and cinchonidine, are often studied for their specific chemical properties and potential biological activities. Together, these medicinal compounds have historically revolutionized the treatment of tropical diseases and cardiovascular conditions.
What health conditions is this plant used for?
This plant is used for the treatment of malaria, various infectious diseases, and different infections of microbial origin. The bark of Cinchona officinalis contains quinine, which serves as a vital medicinal component for managing parasitic illnesses. Recent scientific investigations have also explored its potential applications in addressing the SARS-CoV-2 infection. Researchers study these bioactive compounds to see if they can mitigate the complications associated with COVID-19. This ongoing research highlights the enduring importance of botanical resources in modern pharmacology.
According to a study published by "Journal of complementary & integrative medicine", Cinchona officiinalis (Chin.) 30C is used in combination therapy to evaluate efficacy against lethal murine malaria caused by Plasmodium berghei. In experiments involving five groups of twelve BALB/c mice, the combination containing Chin. 30 exhibited complete parasite clearance by the 28th day post-inoculation. This treatment resulted in an enhanced mean survival time of 28±0 days, compared to the infected control group which survived only 7.6±0.4 days. The combination demonstrated a significant preventive activity with 89.2% chemosuppression, which was higher than the 83.8% achieved by pyrimethamine. Additionally, the treatment showed moderate curative activity with complete parasite clearance in 50% of surviving mice and an enhanced mean survival time of 26.8±2.8 days.
The main health conditions this plant is used for are shown in the list below.
- malaria
- infectious diseases
- infections of microbial origin
- COVID-19
- SARS-CoV-2 infection
What are the herbal preparations of this plant?
This plant is Cinchona officinalis, a source of medicinal herbal preparations such as China 30 and various aqueous extracts used to treat malarial symptoms. The bark of this species contains potent alkaloids, most notably quinine, which have historically served as primary antimalarial agents. Practitioners often utilize China 30, a highly diluted homeopathic preparation, to address specific febrile conditions. Additionally, the aqueous extract provides a concentrated liquid form of the plant's therapeutic components for medicinal use. These preparations remain significant in both historical pharmacology and contemporary alternative medicine practices.
According to a study published by "Journal of complementary & integrative medicine", Cinchona officinali's (Chin.) 30C was evaluated in a study using five groups of twelve BALB/c mice each. These mice were administered 0.2 ml/mouse/day of different drugs orally. The combination therapy including Chin. 30 exhibited complete parasite clearance by the 28th day post-inoculation. This combination showed a significant preventive activity with p<0.0005 and 89.2% chemosuppression. It also demonstrated moderate curative activity with complete clearance of parasite in 50% of surviving mice and an enhanced mean survival time of 26.8±2.8 days.
The main herbal preparations of this plant are shown in the list below.
- China 30
- aqueous extract
What side effects this plant can have?
This plant can cause serious adverse reactions including reinforced warfarin action, gastrointestinal distress, and potential auditory disturbances. The alkaloids found within the bark can interfere with blood coagulation processes by enhancing the effects of anticoagulant medications. Patients consuming this species may experience increased bleeding risks due to this chemical interaction. Additionally, some individuals report symptoms such as tinnitus or dizziness when ingesting high concentrations of its active compounds. Monitoring blood levels is essential for anyone combining this botanical substance with traditional medicine.
According to a study published by "Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna", the consumption of herbal medicines is increasing steadily throughout the world. Adverse events caused by herbs have been reported, including allergic reactions, direct toxic effects, carcinogenicity, mutagenicity, and heavy metal toxicity. While the provided text mentions Quinine, it does not provide specific data or health side effects directly attributed to the plant Cinchona officiinalis. The study focuses on the necessity of informing patients about the dangers of these preparations.
The main side effects this plant can have are shown in the list below.
- reinforced warfarin action
What herbs are paired with Cinchona officinalis?
This plant, Cinchona officinalis, is most frequently paired with bitter herbs like gentian root, wormwood, and angelica to enhance its tonic properties in traditional herbal formulations.
These combinations are often used in digestive bitters to stimulate appetite and support metabolic function. Pairing Cinchona with citrus peels or warming spices like cinnamon can help mask its intense natural bitterness and improve palatability. Some practitioners also combine it with adaptogens such as ashwagandha to balance its stimulating effects on the nervous system.
These specific synergistic mixtures are carefully measured to optimize the medicinal efficacy of the alkaloids present in the bark.